US$ 26.40
semaglutide with high blood pressure and Pressure: Blood Benefits New weight loss medication may
Description
Among participants receiving 36 mg, 54.6% lost at least 10% of their body weight and 36.0% lost at least 15%

Wegovy is now available as a daily pill (approved January 2026), and orforglipron (Foundayo by Eli Lilly) is an emerging oral small-molecule GLP-1 option

Even after reaching the weight goal established with a provider, discontinuing GLP-1s doesn't necessarily mark the end of the treatment journey

93 WaqasACorreiaJCAhmadMAkhtarTNMerajHAngelakisIet al
